The attention of the National Agency for Food and Drug Administration and Control (NAFDAC) has been drawn to the recall of three brands of Fleming pharmaceutical products on November 14, 2016 by the Hong Kong Department of Health (DH) over misinformation of the package label instruction which do not match with the registered version, thereby rendering the products unregistered and unsafe for human consumption. The products which contained amoxicillin and clavulanic acid were supplied by Hong Kong-based Medreich Pharmaceutical franchise, Medreich Far East Limited.
THE RECALLED PRODUCT DETAILS:
|PRODUCT NAME||REGISTRATION NUMBER|
|Fleming Tablets 1g||HK- 52242|
|Fleming for oral suspension 457mg/5m||HK- 56072|
|Fleming for suspension 228.5mg/5ml||HK- 56069|
HEALTHCARE PROVIDER’S ACTION
- Healthcare providers and patients in possession of these affected products should stop using them.
NAFDAC........Safeguarding the Health of the Nation!!!